Literature DB >> 9059181

Third trimester fetal growth and measures of carbohydrate and lipid metabolism in umbilical venous blood at term.

J A Spencer1, T C Chang, D Crook, A Proudler, C V Felton, S C Robson, M Hauesler.   

Abstract

AIM: To compare measures of carbohydrate and lipid metabolism in umbilical venous blood after birth at term in pregnancies with normal and retarded fetal growth during the third trimester.
METHODS: Three groups of pregnancies reaching term, in which fetal growth had been prospectively monitored by repeated ultrasound measurements during the third trimester, were studied. Sequential fetal abdominal circumference measurements remained above the 10th centile in 42 (normal size, normal growth group), below the 10th centile but did not depart further than 1.5 SD (small, normal growth group), or below the 10th centile and subsequently fell away by more than 1.5 SD before delivery (small, growth retarded group). Birthweight, neonatal morphometric measures (ponderal index, mid arm:head circumference ratio, subscapular and triceps skinfold thickness), umbilical venous blood concentrations of glucose, insulin, pro-insulin, des 31,32 proinsulin, total cholesterol, free cholesterol, cholesterol ester, triglycerides, lipoprotein (a), apolipoprotein A-1 and apolipoprotein B were measured.
RESULTS: The median birthweight of the three groups was significantly different (3570, 2569, and 2277 g, respectively). Median values of ponderal index and mid arm:head circumference ratio were significantly lower in the small, growth retarded group and did not differ between the small and normal size groups with normal growth. Both groups with small fetuses had significantly lower mean glucose and cholesterol ester concentrations, and higher mean free cholesterol:cholesterol ester ratios, compared with the normal size, normal growth group. The group showing fetal growth retardation had mean total cholesterol and mean cholesterol ester concentrations that were significantly lower than those of both the other two groups. Mean des 31,32 proinsulin concentrations were low in both groups of small fetuses, but only significantly so in the group without fetal growth retardation. Mean insulin, proinsulin, free cholesterol, triglycerides, lipoprotein(a), apolipoprotein A-1, apolipoprotein B concentrations and the ratio of A-1:B were similar in all three groups.
CONCLUSION: The similarity in the umbilical venous blood carbohydrate and lipid profile at term between pregnancies with documented third trimester fetal growth retardation and those with "genetically" small babies argues against a major role for intrauterine nutritional deprivation as a cause for the association between birth-weight and subsequent adult disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059181      PMCID: PMC1720609          DOI: 10.1136/fn.76.1.f21

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  29 in total

1.  The effects of labor on maternal and fetal levels of insulin-like growth factor binding protein-1.

Authors:  F A Hills; R Crawford; S Harding; A Farkas; T Chard
Journal:  Am J Obstet Gynecol       Date:  1994-11       Impact factor: 8.661

2.  Endocrine and metabolic adaptation following caesarean section or vaginal delivery.

Authors:  J A Bird; J A Spencer; T Mould; M E Symonds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

3.  Weight in infancy and death from ischaemic heart disease.

Authors:  D J Barker; P D Winter; C Osmond; B Margetts; S J Simmonds
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  Neonatal morphometrics and perinatal outcome: who is growth retarded?

Authors:  R M Patterson; M R Pouliot
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

5.  Fetal head and abdominal circumferences: II. A critical re-evaluation of the relationship to menstrual age.

Authors:  R L Deter; R B Harrist; F P Hadlock; R J Carpenter
Journal:  J Clin Ultrasound       Date:  1982-10       Impact factor: 0.910

6.  Growth in utero and serum cholesterol concentrations in adult life.

Authors:  D J Barker; C N Martyn; C Osmond; C N Hales; C H Fall
Journal:  BMJ       Date:  1993-12-11

7.  Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements.

Authors:  A J Proudler; I F Godsland; J C Stevenson
Journal:  Metabolism       Date:  1994-04       Impact factor: 8.694

8.  Third trimester fetal growth and umbilical venous blood concentrations of IGF-1, IGFBP-1, and growth hormone at term.

Authors:  J A Spencer; T C Chang; J Jones; S C Robson; M A Preece
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

9.  The differential neonatal morbidity of the intrauterine growth retardation syndrome.

Authors:  J Villar; M de Onis; E Kestler; F Bolaños; R Cerezo; H Bernedes
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

10.  Plasma insulin in appropriate- and small-for-gestational-age fetuses.

Authors:  D L Economides; A Proudler; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

View more
  5 in total

1.  Global protein synthesis in human trophoblast is resistant to inhibition by hypoxia.

Authors:  S F Williams; E Fik; S Zamudio; N P Illsley
Journal:  Placenta       Date:  2011-11-10       Impact factor: 3.481

2.  NDRG1 deficiency attenuates fetal growth and the intrauterine response to hypoxic injury.

Authors:  Jacob Larkin; Baosheng Chen; Xiao-Hua Shi; Takuya Mishima; Koichi Kokame; Yaacov Barak; Yoel Sadovsky
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

3.  Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction.

Authors:  Ulrich Pecks; Werner Rath; Nicolai Maass; Bartlomiej Berger; Imke Lueg; André Farrokh; Sabrina Farrokh; Christel Eckmann-Scholz
Journal:  Lipids Health Dis       Date:  2016-11-14       Impact factor: 3.876

4.  Apolipoprotein E Genotype in Very Preterm Neonates with Intrauterine Growth Restriction: An Analysis of the German Neonatal Network Cohort.

Authors:  Stephen Norda; Tanja K Rausch; Thorsten Orlikowsky; Matthias Hütten; Sören Schulz; Wolfgang Göpel; Ulrich Pecks
Journal:  Biomed Res Int       Date:  2017-04-05       Impact factor: 3.411

5.  Estimating fetal cholesterol synthesis rates by cord blood analysis in intrauterine growth restriction and normally grown fetuses.

Authors:  Ulrich Pecks; Verena Bornemann; Anika Klein; Laura Segger; Nicolai Maass; Ibrahim Alkatout; Christel Eckmann-Scholz; Mohamed Elessawy; Dieter Lütjohann
Journal:  Lipids Health Dis       Date:  2019-10-25       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.